Tarsus Pharmaceuticals Inc.

(NASDAQ: TARS) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.

Contact Information

Website: www.tarsusrx.com
Email: info@tarsusrx.com
Main Phone: +1 949 409-9820
Address: 15440 Laguna Canyon Road
Address 2: Suite 160
State: CA
City / Town: Irvine
Country: US
Postal Code: 92618

Issuer Information

Exchange: NGS
CEO: Bobak Azamian
Employees: 18
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A